FDA Inspection 806013 — Joseph C Gathe, Jr, MD, CI
The FDA completed an inspection of Joseph C Gathe, Jr, MD, CI on November 5, 2012 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 5, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Houston, TX (United States)
Additional Details
Clinical Investigator (CI)